2 results
Approved WMOCompleted
Analyze whether application of a theoretical reasoned and tested system with test subjects is preventive and costs effective.
Approved WMOWill not start
To assess the safety and tolerability profile of durvalumab monotherapy, durvalumab + novel oncology therapy, durvalumab + chemotherapy, anddurvalumab + novel oncology therapy + chemotherapy combinations